News

News

Press Release | Adalta Secures AD-214 Resupply Under KBI Biopharma MSA

Learn More
News

Press Release |Selexis and KBI Biopharma Enter into Agreements with Immatics for Integrated Approach to Advance Immatics TCR Bispecific Program Towards IND

Learn More
News

Press Release | KBI Biopharma Enters Commercial Manufacturing Agreement with AM-Pharma to Prepare for the Commercial Launch of Lead Program in Acute Kidney Disease

Learn More
News

Press Release | Durham Tech and KBI BioPharma Partner to Boost Diversity and Create Life Sciences Job Opportunities for North Carolina Students and Veterans

Learn More
News

BioPharm International | Maximum Output Starts with Optimized Upstream Processing

Learn More
News

Press Release | KBI Biopharma Expands US Operations With New $150 Million Commercial Manufacturing Facility Based In RTP, North Carolina

Learn More
News

Press Release | JSR Life Sciences Expands Its European Gene-to-GMP Biologics Manufacturing Facilities For Selexis And KBI Biopharma In Geneva, Switzerland

Learn More
News

Press Release | JSR Life Sciences Company KBI Biopharma, Inc. Promotes Dirk Lange to CEO

Learn More
News

Press Release | AbSci Closes $15.4 M in Series D Funding to Accelerate Growth and Scale Disruptive Protein PrintingTM Technology, Announces Exclusive Co-Marketing Partnership with KBI Biopharma

Learn More
News

Press Release | ZyVersa Therapeutics to Advance Development of Its Lead Inflammasome Inhibitor with Selexis and KBI Biopharma’s Integrated Development Platform

Learn More
Page 1 of 6